Executive and Socio-cognitive Functions in Survivors of Primary Brain Tumor: Impact on Patients' Quality of Life (NEUROCOG-QOL)
Assessment of Executive and Socio-cognitive Functions in Child and Adult Survivors of Primary Brain Tumor: Impact on Patients' and Relatives' Quality of Life.
Sponsor: University Hospital, Angers
Listed as NCT02693405, this NA trial focuses on Neurocognition and Primary Brain Tumor and remains ongoing. Sponsored by University Hospital, Angers, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Jun 2020 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
▶ Show 2 earlier versions
-
Mar 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Angers
For direct contact, visit the study record on ClinicalTrials.gov .